Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility.

PubWeight™: 2.96‹?› | Rank: Top 1%

🔗 View Article (PMID 1519566)

Published in Am J Gastroenterol on September 01, 1992

Authors

J R Jamieson1, H J Stein, T R DeMeester, L Bonavina, W Schwizer, R A Hinder, M Albertucci

Author Affiliations

1: University of Southern California School of Medicine, Department of Surgery, Los Angeles.

Associated clinical trials:

Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy | NCT01328652

Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule | NCT00579410

Articles citing this

Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc (2010) 2.59

Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg (1995) 2.17

Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci (1999) 1.98

Simultaneous monitoring of gastric and oesophageal pH reveals limitations of conventional oesophageal pH monitoring in milk fed infants. Arch Dis Child (2001) 1.87

The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg (1998) 1.81

Minimally invasive surgery for achalasia: an 8-year experience with 168 patients. Ann Surg (1999) 1.75

Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg (1997) 1.58

Role of esophageal function tests in diagnosis of gastroesophageal reflux disease. Dig Dis Sci (2001) 1.21

Importance of reflux symptoms in functional dyspepsia. Gut (1995) 1.12

Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia. Dig Dis Sci (1999) 1.09

A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease. Gut (2009) 1.08

Clinical distinct features of noncardiac chest pain in young patients. J Neurogastroenterol Motil (2010) 1.07

The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann Surg (2006) 1.04

Antireflux surgery for patients with end-stage lung disease before and after lung transplantation. Surg Endosc (2007) 1.04

Reflux oesophagitis in adult coeliac disease: beneficial effect of a gluten free diet. Gut (2003) 1.00

Effect of partial and total laparoscopic fundoplication on esophageal body motility. Surg Endosc (2006) 0.97

Pharyngeal swallowing. The major factor in clearance of esophageal reflux episodes. Ann Surg (1993) 0.96

Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc (2014) 0.94

Ingestion of acidic foods mimics gastroesophageal reflux during pH monitoring. Dig Dis Sci (2005) 0.93

Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg (2002) 0.91

Validation of a new method of measuring esophageal acid exposure: comparison with 24-hour pH monitoring. Dig Dis Sci (2003) 0.91

24-h pH monitoring for gastroesophageal reflux disease: already standard but not yet gold? Am J Gastroenterol (1992) 0.90

Accurate positioning of the 24-hour pH monitoring catheter: agreement between manometry and pH step-up method in two patient positions. World J Gastroenterol (2007) 0.87

Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux. World J Gastroenterol (2007) 0.87

Gastroesophageal reflux disease in COPD: links and risks. Int J Chron Obstruct Pulmon Dis (2015) 0.85

Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. World J Gastroenterol (2006) 0.85

Long-term outcomes of laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)-related airway disorder. Surg Endosc (2006) 0.84

Ambulatory pH: monitoring with a wireless system. Surg Endosc (2007) 0.84

Normal ambulatory 24-hour esophageal pH values in Koreans -a multicenter study-. J Korean Med Sci (2008) 0.83

Obese patients have stronger peristalsis and increased acid exposure in the esophagus. Dig Dis Sci (2010) 0.82

Esophageal manometry and 24-hour pH monitoring to evaluate laparoscopic Lind fundoplication in gastroesophageal reflux disease. JSLS (1999) 0.82

Gastroesophageal reflux disease and esophageal motility in morbidly obese patients submitted to laparoscopic adjustable silicone gastric banding or laparoscopic vertical banded gastroplasty. Surg Endosc (2010) 0.82

The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan. J Gastroenterol (2006) 0.81

Comparison of gastroesophageal reflux in 100 patients with or without prior gastroesophageal surgery. J Gastroenterol (2009) 0.80

Dual-channel ambulatory esophageal pH monitoring. A useful diagnostic tool? Dig Dis Sci (1997) 0.80

Discussing the influence of electrode location in the result of esophageal prolonged pH monitoring. BMC Gastroenterol (2014) 0.80

Correlation between hypersensitivity induced by esophageal acid infusion and the baseline impedance level in patients with suspected gastroesophageal reflux. J Gastroenterol (2014) 0.79

The utility of ambulatory pH monitoring in patients presenting with chronic cough and asthma. Can J Gastroenterol (2007) 0.79

Clinical utility and tolerability of JSPH-1 wireless esophageal pH monitoring system. BMC Gastroenterol (2013) 0.79

Wireless pH-metry at the gastrojejunostomy after Roux-en-Y gastric bypass: a novel use of the BRAVO™ system. Surg Endosc (2011) 0.78

Diagnostic interpretation of extended pH monitoring: is there a single best method? Dig Dis Sci (2005) 0.78

Effect of aging on esophageal motility in patients with and without GERD. Ger Med Sci (2011) 0.78

Significance of the lower esophageal sphincter preservation in preventing alkaline reflux esophagitis in patients after total gastrectomy reconstructed by Roux-en-Y for gastric cancer. Int Surg (2014) 0.78

Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results. Surg Endosc (2015) 0.77

Ambulatory esophageal pH monitoring: technique, interpretations, and clinical indications. Dig Dis Sci (2002) 0.77

Pathological basis of gastroesophageal reflux disease. World J Surg (2003) 0.76

Ratio between proximal/distal gastroesophageal reflux does not discriminate abnormal proximal reflux. World J Surg (2014) 0.76

Endoscopic pH monitoring for patients with suspected or refractory gastroesophageal reflux disease. Can J Gastroenterol (2007) 0.76

Obesity is associated with increasing esophageal Acid exposure in korean patients with gastroesophageal reflux disease symptoms. J Neurogastroenterol Motil (2013) 0.76

Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors. BMC Gastroenterol (2008) 0.75

How to Interpret Ambulatory 24 hr Esophageal pH Monitoring. J Neurogastroenterol Motil (2010) 0.75

Impairment of secondary peristalsis in Barrett's esophagus by transnasal endoscopy-based testing. World J Gastroenterol (2014) 0.75

Correlation between the different pH-metry scores in gastroesophageal reflux disease in children. Medicine (Baltimore) (2016) 0.75

Prolonged 2-day esophageal pH-metry with impedance monitoring improves symptom-reflux association analysis. Dig Dis Sci (2013) 0.75

Laryngopharyngeal reflux: Current opinion. Indian J Otolaryngol Head Neck Surg (2005) 0.75

Is the proton pump inhibitor test helpful in patients with laryngeal symptoms? Dig Dis Sci (2013) 0.75

Ingested acidic food and liquids may lead to misinterpretation of 24-hour ambulatory pH tests: focus on measurement of extra-esophageal reflux. Dig Dis Sci (2007) 0.75

Double probe pH-monitoring findings in patients with benign lesions of the true vocal folds: comparison with typical GERD and the effect of smoking. Eur Arch Otorhinolaryngol (2011) 0.75

Mucosal perforation during laparoscopic surgery for achalasia: impact of preoperative pneumatic balloon dilation. Surg Endosc (2016) 0.75

Are there any differences between nutcracker esophagus with and without reflux? Dysphagia (2007) 0.75

Articles by these authors

Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil (2012) 7.24

Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg (1998) 4.95

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg (1998) 4.86

Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg (1980) 4.60

Dating the rise of atmospheric oxygen. Nature (2004) 4.29

Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg (1986) 4.22

Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res (2001) 3.70

High-resolution manometry predicts the success of oesophageal bolus transport and identifies clinically important abnormalities not detected by conventional manometry. Neurogastroenterol Motil (2004) 3.44

Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg (1994) 3.09

Boerhaave's syndrome: analysis of the literature and report of 18 new cases. Dis Esophagus (1997) 3.06

Conscious sedation for gastroscopy: patient tolerance and cardiorespiratory parameters. Gastroenterology (1995) 2.91

Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg (1983) 2.91

Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg (2000) 2.85

Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res (2000) 2.73

A contemporaneous comparison of hospital charges for laparoscopic and open Nissen fundoplication. Surg Endosc (1995) 2.59

Development of Myocardial Necrosis and Absence of Nerve Degeneration in Thiamine Deficiency in Pigs. Am J Pathol (1943) 2.56

Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg (1992) 2.54

Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate. J Am Coll Surg (2000) 2.53

Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg (2001) 2.49

Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg (1995) 2.44

Ingested foreign bodies within the appendix: A 100-year review of the literature. Dig Dis (1999) 2.39

THE EXCRETION OF SPECIFIC FLUORESCENT SUBSTANCES IN THE URINE IN EXPERIMENTAL NICOTINIC ACID DEFICIENCY. J Clin Invest (1942) 2.39

Transoral access for endoscopic thyroid resection. Surg Endosc (2007) 2.38

Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25

Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol (1986) 2.25

Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients. Aliment Pharmacol Ther (2013) 2.17

The lower esophageal sphincter in health and disease. Am J Surg (1988) 2.17

Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg (1995) 2.17

Local excision and endoscopic posterior mesorectal resection versus low anterior resection in T1 rectal cancer. Br J Surg (2008) 2.14

Gastric emptying and motility: assessment with MR imaging--preliminary observations. Radiology (1998) 2.10

Presentation and surgical management of bronchogenic and esophageal duplication cysts in adults. Chest (1998) 2.07

Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg (1999) 2.07

Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci (1992) 2.04

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04

Five- to eight-year outcome of the first laparoscopic Nissen fundoplications. J Gastrointest Surg (2001) 2.03

Effects of baclofen on the functional anatomy of the oesophago-gastric junction and proximal stomach in healthy volunteers and patients with GERD assessed by magnetic resonance imaging and high-resolution manometry: a randomised controlled double-blind study. Aliment Pharmacol Ther (2014) 1.99

Tracheobronchial lesions following oesophagectomy: prevalence, predisposing factors and outcome. Br J Surg (1998) 1.99

Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin. Am J Surg (1995) 1.98

Management of esophageal perforation. Am J Surg (1980) 1.90

Human gastric pacesetter potential. Site of origin, spread, and response to gastric transection and proximal gastric vagotomy. Am J Surg (1977) 1.88

The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg (1998) 1.81

Acute pancreatitis with hyperlipemia. Surgery (1971) 1.79

Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg (1998) 1.78

Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg (1995) 1.77

Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg (1994) 1.75

Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg (1983) 1.75

Sedation and analgesia for colonoscopy: patient tolerance, pain, and cardiorespiratory parameters. Gastrointest Endosc (1997) 1.74

Pathogenesis of esophagitis in patients with gastroesophageal reflux. Surgery (1980) 1.74

Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut (1996) 1.72

Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer (2001) 1.72

Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg (1982) 1.71

Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery. Am J Surg (1979) 1.69

Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci (1995) 1.69

Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg (1994) 1.68

Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg (2001) 1.66

Laparoscopic Nissen fundoplication: where do we stand? Surg Laparosc Endosc (1997) 1.64

Surgery and the management of peripheral lung tumors adherent to the parietal pleura. J Thorac Cardiovasc Surg (1992) 1.64

Length of the distal esophageal sphincter and competency of the cardia. Am J Surg (1986) 1.64

Pulmonary infections imitating lung cancer: clinical presentation and therapeutical approach. Ir J Med Sci (2012) 1.64

Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg (2000) 1.63

En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg (2008) 1.61

Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg (1999) 1.60

Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study. Ann Surg (1999) 1.60

Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg (2000) 1.59

Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci (1995) 1.58

Computerized identification of pathologic duodenogastric reflux using 24-hour gastric pH monitoring. Ann Surg (1991) 1.58

Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg (1997) 1.58

Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg (2001) 1.55

Cystic and bullous lung disease. Ann Thorac Surg (1991) 1.55

Indications, benefits and outcome of laparoscopic Nissen fundoplication. Dig Dis (1997) 1.54

Immunosuppression in patients with Barrett's esophagus. Surgery (1992) 1.54

Flexible versus rigid endoscopy for treatment of foreign body impaction in the esophagus. Surg Endosc (2007) 1.54

Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reflux. Ann Surg (1987) 1.54

Boerhaave's syndrome: the man behind the syndrome. Dis Esophagus (1997) 1.53

Potentially curable cancer of the esophagus. Cancer (1982) 1.53

Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg (2000) 1.53

[Anastomotic leaks in the upper gastrointestinal tract]. Chirurg (2004) 1.53

The evaluation of objective measurements of gastroesophageal reflux and their contribution to patient management. Surg Clin North Am (1976) 1.52

Physiology of the oesophageal transition zone in the presence of chronic bolus retention: studies using concurrent high resolution manometry and digital fluoroscopy. Neurogastroenterol Motil (2008) 1.52

[Comparison of the quality of life after subtotal and total gastrectomy for stomach carcinoma]. Dtsch Med Wochenschr (1996) 1.50

Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg (1992) 1.50

Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment. Dig Dis (1996) 1.49

Talc pleurodesis: talc slurry versus thoracoscopic talc insufflation in a porcine model. Ann Thorac Surg (1996) 1.49

Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg (1985) 1.48

Twenty-four-hour gastric luminal pH in normal subjects: influence of probe position, food, posture, and duodenogastric reflux. Am J Gastroenterol (1994) 1.48

Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg (2001) 1.48

Enucleation of submucosal tumors of the esophagus: minimally invasive versus open approach. Surg Endosc (2004) 1.46

Citric Acid cycle activity in mitochondria isolated from mung bean hypocotyls. Plant Physiol (1976) 1.46

The hypertensive lower esophageal sphincter. Am J Surg (1996) 1.45

The use of ultrasound to differentiate rectus sheath hematoma from other acute abdominal disorders. Surg Endosc (1999) 1.44

Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus. Surgery (1989) 1.44